Exosome production scale-up – customer references

Exploring the Role of Osteosarcoma-Derived Extracellular Vesicles in Pre-Metastatic Niche Formation and Metastasis in the 143-B Xenograft Mouse Osteosarcoma Model: Alekhya Mazumdar et al. Cancers 2020,12,3457 [open access]… “Both 2D and 3D EVs were used in two independent experiments, and no difference in outcome was observed between the two sources of EVs.”

Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming: Alekhya Mazumdar et al. IJMS 21 (15) 2020 [open access]… “Alternatively, to obtain large amounts of EVs from 143-B cells, a bioreactor culture was set-up. A medium-sized, hollow-fiber culture cartridge with a 20 kDa molecular weight cut-off (C2011, Fibercell Systems; Frederick, MD, USA) was pre-cultured according to the manufacturer ’s instructions. 143-B cells stably expressing mCherry, luciferase and LacZ [41,42] were expanded in conventional culture flasks and 10^8 cells were used to inoculate the hollow-fiber culture cartridge. “

Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle Mariana Conceicao et al. [open access]… “For in vivo experiments, FiberCell hollow fiber bioreactors with 20 kDa cutoff hydrophilic fibers (KDBIO, Berstett, France) were used for large-scale production of MSC-derived EVs, according to manufacturer’s instructions.”

AL-PHA beads: bioplastic-based protease biosensors for global health applications:Richard Kelwick et al. [open access]… “HEK293 cells were cultured at a high cell density using a hollow fibre bioreactor(FiberCell Systems, Inc., MD, USA), whichwas configured with a 20 kDamolecular weight cut off cartridge(#C2011, FiberCell Systems, Inc., MD, USA)that essentially concentrated HEK293 cells (up to ~109cells) and their secretomes (>20 kDa proteins and EVs) within ~20 ml cartridge/harvest volumes.”

Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury: Cao et al; Stem Cell Research and Therapy (2020) 11:206 [open access]… “In summary, our findings demonstrate that the hollow fiber 3D culture system provides an efficient strategy for the continuous production of MSC-exos which has enhanced therapeutic potential for cisplatin-induced AKI.”

Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity: Litao Yan & Xing Wu; Cell Biol Toxico (Dec 09 2019) [open access]… “our study provides novel insights into the chondroprotective properties of exosomes derived from the 3D culture of U-MSCs in a hollow-fiber bioreactor. More specifically, 3D-Exos increased the number and enhance the function of chondrocytes by stimulating cell proliferation, migration, and matrix synthesis, and inhibiting apoptosis. Because of its enhanced biological function and yield, 3D-Exos may represent a promising therapeutic method for the treatment of cartilage defects…”

Urine-derived stem cells facilitate endogenous spermatogenesis restoration of busulfan-induced non-obstructive azoospermic mice by paracrine exosomes. Cuncan DengYun Xie et al.; Stem Cells and Development (Jul 16 2019) [abstract]… “Our data demonstrated that transplantation of USC‐exos was able to promote spermatogenesis in the testes of  busulfan‐induced NOA mice. The possible mechanism might lay in the abundant miRNAs carried in USC‐exos…”

Extracellular Vesicles From Human Urine-Derived Stem Cells Ameliorate Erectile Dysfunction in a Diabetic Rat Model by Delivering Proangiogenic MicroRNA: Ouyang B. et al.; Sexual Medicine (2019) [open access]...Author describes high density culture of stem cells in the FiberCell Systems hollow fibre bioreactor. “Our data indicate that USC-EVs enhance the expression of endothelial cell markers, reduce collagen deposition, and improve the neurogenic-mediated erectile response in DED rats. The improvement in DED in a rodent model after administration of USC-EVs is similar to that seen after cell therapy with USCs or other types of MSCs. The cargo of proangiogenic miRNA may play an important role in endothelial repair.”

Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift: Park, JE et al.; Oncogene (2019) [abstract] ... “B16-F0, A375, A431, orA549 cells were inoculated into the extra-capillary space of each cartridge and allowed to attach to the fiber surface over 24 h. Cancer cells were maintained in DMEM supplemented with 5% Chemically Defined Medium for High Density cell culture (CDM-HD; Fibercell). CDM-HD, a chemically defined protein-free serum replacement, was used to avoid contamination of FBS-derived exosomes”. Author describes use of hollow fibre culture system and workflow of exosome isolation.

Large-scale preparation of extracellular vesicles enriched with specific micro-RNA: Yoo, KW et al. ; Tissue Engineering. 2018 [abstract] “The hollow fiber bioreactor system allows high-density culture of EV-producing cells, and the 20 kDa cutoff of the fiber allows nutrients and waste products to pass through but retains EVs (40–1000nm in diameter, molecular weight >500 kDa). We grew the HEK293-mir-133a, HEK293-mir-202, and HEK293-mir-NT cells in the system for >30 days, and collected 50mL of EV-enriched supernatant every 1 or 2 days. We discontinued the cultures only because we collected enough supernatant. Compared with supernatants of
conventional 2D cultures, expression of miR-133a-3p and miR-202-5p in the supernatants collected from the bioreactors contained 4.3-fold more miR-133a-3p or miR-202-5p in EVs. We did not compare the copy numbers of miRNA molecules per EV particle. However, we posit that higher EV particle concentrations in the supernatant could be one of the mechanisms of the increased miRNA yields. Thus the bioreactor can be used to prepare miRNA-enriched EVs continuously.”

Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes: Watson,D.C. et al.; J Extracell Vesicles. 2018 Feb 28;7(1) [open acccess] “This method can be used to produce ~40-times more EV per mL medium than conventional cell culture, and in addition these preparations lack animal proteins present in serum-supplemented media. This platform was used in the current study, and allowed the production of several litres of serum-free, EV-rich medium to be generated.”

Use of a Hollow Fiber Bioreactor to Collect Extracellular Vesicles from Cells in Culture: Yan IK et al.; Methods Mol Biol. 2018;1740:35-41 [abstract]…Author provides rationale for using FiberCell HFBR and a more-or-less complete protocol for using the system to generate concentrated EVs

Clinical Scale Production and Wound Healing Activity of Human Adipose Derived Mesenchymal Stem Cell Extracellular Vesicles from a Hollow Fiber Bioreactor. [Fibercell Poster ISEV2017]

Efficient production and enhanced tumor delivery of engineered extracellular vesicles: Watson DC et al.; Biomaterials 105, 2016: 195-205 [open access]…“…these data suggest that the use of hollow-fiber bioreactor, serum-free media [CDM-HD] and an optimized purification protocol represent a superior method to achieve high yield of purified EV (yields were >3 mg/week from a single lab-scale [20ml, Medium Size] culture cartridge)..”

Comparative Secretome Analyses Using a Hollow Fiber Culture System with Label-Free Quantitative Proteomics Indicates the Influence of PARK7 on Cell Proliferation and Migration/Invasion in Lung Adenocarcinoma: Ying-Hua Chang et al, J. Proteome Res. 2012, 11, 11, 5167-5185 [abstract]

Review papers and articles

Recent Advances in Extracellular Vesciles as Drug Delivery Systems and Their Potential in Precision Medicine: de Jong,B. et al; Pharmaceutics 2020,12,1006 [open access]

Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications: Tsiapalis, D. & O’Driscoll, L.; Cells 2020, 9, 991[open access]

Human Pluripotent Stem Cell-Derived Extracellular Vesicles:Characteristics and Applications TISSUE ENGINEERING Part B Vol 26 N° 2 2020 [open access]

Exosome manufacturing statusFuture Med. Chem.(2019) 11(10), 1225–123 [open access]